Robert Kramer - Feb 23, 2022 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
President and CEO, Director
Signature
/s/ S. Scott Lieberman, Attorney-in-fact
Stock symbol
EBS
Transactions as of
Feb 23, 2022
Transactions value $
-$146,308
Form type
4
Date filed
2/25/2022, 04:18 PM
Previous filing
Feb 24, 2022
Next filing
Mar 2, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Tax liability -$59.9K -1.42K -0.87% $42.23* 161K Feb 23, 2022 Direct F1
transaction EBS Common Stock Tax liability -$86.4K -2.03K -1.26% $42.47* 159K Feb 24, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld by the Company in exchange for payment of the employee's withholding taxes.